Fundz

Fundz Deep Dive

Everything you need to win Inocras & Summit Pharmaceuticals International Corporation — in one platform.

Who to reach, what to say, and why now on Inocras & Summit Pharmaceuticals International Corporation — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Inocras & Summit Pharmaceuticals International Corporation — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Inocras and Summit Pharmaceuticals International Corporation Collaborate to Revolutionize Healthcare in Japan

Nov 06, 2024•over 1 year ago

Contract Type

partnership

San DiegoBiotechnologyHealth CareGenetics

Description

Inocras Inc. and Summit Pharmaceuticals International Corporation have signed a Memorandum of Understanding to jointly explore the commercialization of whole genome sequencing (WGS) analysis services in Japan. The collaboration aims to leverage genomic data and bioinformatics to revolutionize healthcare in Japan by better understanding and treating genetic conditions, especially cancer.

Company Information

Company

Inocras & Summit Pharmaceuticals International Corporation

Location

San Diego, California, United States

About

Inocras Inc. and Summit Pharmaceuticals International Corporation are collaborating to bring advanced whole genome sequencing (WGS) and bioinformatics services to Japan's healthcare system, aiming to better understand and treat genetic conditions, especially cancer.

Predictive Intelligence
Strategic

ML-powered predictions for Inocras & Summit Pharmaceuticals International Corporation's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.